Carbohydrate analysis throughout the development of a protein therapeutic.
about
Impact of glycosylation on the unimpaired functions of the spermFc glycans of therapeutic antibodies as critical quality attributesGlycan analysis of therapeutic glycoproteinsHigh throughput quantification of N-glycans using one-pot sialic acid modification and matrix assisted laser desorption ionization time-of-flight mass spectrometryImplications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins.LC-MS/MS biopharmaceutical glycoanalysis: identification of desirable reference material characteristics.CHOPPI: a web tool for the analysis of immunogenicity risk from host cell proteins in CHO-based protein production.High-throughput glycosylation analysis of therapeutic immunoglobulin G by capillary gel electrophoresis using a DNA analyzerAnalysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeuticsA combined system for engineering glycosylation efficiency and glycan structure in Saccharomyces cerevisiaeThe use of lectin microarray for assessing glycosylation of therapeutic proteins.Glycan analysis by modern instrumental methods.The sweet tooth of biopharmaceuticals: importance of recombinant protein glycosylation analysis.The third dimension of reading the sugar code by lectins: design of glycoclusters with cyclic scaffolds as tools with the aim to define correlations between spatial presentation and activity.Impact of physiochemical properties on pharmacokinetics of protein therapeutics.State-of-the-art technologies for rapid and high-throughput sample preparation and analysis of N-glycans from antibodies.High-yield secretion of recombinant proteins from the microalga Chlamydomonas reinhardtii.Engineering yeast for producing human glycoproteins: where are we now?Galactosylation variations in marketed therapeutic antibodies.N-Glycosylation of Cholera Toxin B Subunit: Serendipity for Novel Plant-Made Vaccines?Of [Hamsters] and men: a new perspective on host cell proteins.Characterizing the glycosylation state of therapeutic recombinant glycoproteins.Multidimension cultivation analysis by standard and omics methods for optimization of therapeutics production.Profiling N-linked oligosaccharides from IgG by high-performance anion-exchange chromatography with pulsed amperometric detection.High yield process for the production of active human α-galactosidase a in CHO-K1 cells through lentivirus transgenesis.Polyoxometalates as sialidase mimics: selective and non-destructive removal of sialic acid from a glycoprotein promoted by phosphotungstic acid.Generation of Recombinant N-Linked Glycoproteins in E. coli.
P2860
Q26782562-842495EA-0E1E-450A-806A-748ECA3C2D7BQ26799266-5CA72F81-E5A1-4F80-85BA-79F07E3DA6F3Q28082842-36AA3CEC-9099-4125-8C2C-7A84A15697FFQ33619621-4AFA0C01-5FA7-4FE5-8C9E-F38A6B502CF8Q34127850-6DB2A3C6-45D0-4A40-82D9-9C7E50D5B8ADQ34165960-16088BC3-DD58-4DF3-A9CD-814EADC5219BQ34803518-DD62524D-A149-4061-AE1F-95238AB1838DQ35019925-160560DA-1AE5-4F80-B156-CA33173F7E45Q35174495-2EC70A84-7F64-4935-8B5D-7E3DF9B958DDQ35223810-A8134FC3-7F8C-46E4-8875-B389241283F6Q36598969-A5D4F3DF-FEF8-4728-B7EE-CF104D548662Q37138938-6AB4C698-DEE2-49E9-BB4E-49535A870964Q37829419-E325B591-9FBD-46BB-A082-8DF954B0AF5CQ38029304-EDA59956-E145-4DEC-A7C7-DF84C818EB74Q38096239-6C394938-67A1-4200-B6AA-FA76981D5BD4Q38098934-48090443-37D0-4C5E-90DA-6275B292E342Q38717803-3F750933-06C8-4654-A020-98BA6F0331DDQ38957230-97163B07-6BF0-4DD1-84DC-A3F3452BBC1BQ39055068-1FF96E38-14BD-44B3-8A7F-FCB22FC4729EQ39359356-06E46643-E6D4-4489-9F7D-1D34533560D3Q40143890-0AC15EC3-A2F5-4516-9D38-AD5CF0179059Q41870889-7809F993-0903-42FC-954D-FAA5BCDC44B6Q45884176-4AE4CA2E-E8F3-425A-BAAE-724ACD38C3D8Q46427932-76E48DB0-0712-4DE3-B999-B014C6C839EAQ46608396-31F10C06-BB02-478F-9726-5C8223F89AECQ47288227-57087CD2-2056-42EE-A15F-5BDDD30976DAQ47810250-9EDE69DC-8945-49CD-BAB6-B3B6C22BF00DQ50889846-D933D799-13A0-468E-90EA-756040FFA7A5
P2860
Carbohydrate analysis throughout the development of a protein therapeutic.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Carbohydrate analysis throughout the development of a protein therapeutic.
@en
Carbohydrate analysis throughout the development of a protein therapeutic.
@nl
type
label
Carbohydrate analysis throughout the development of a protein therapeutic.
@en
Carbohydrate analysis throughout the development of a protein therapeutic.
@nl
prefLabel
Carbohydrate analysis throughout the development of a protein therapeutic.
@en
Carbohydrate analysis throughout the development of a protein therapeutic.
@nl
P2860
P1476
Carbohydrate analysis throughout the development of a protein therapeutic.
@en
P2093
Elizabeth Higgins
P2860
P2888
P304
P356
10.1007/S10719-009-9261-X
P577
2009-11-04T00:00:00Z
2010-02-01T00:00:00Z